$5650 | Single User
$6650 | Multi User
$8150 | Corporate License
$10000 | Global License

Veterinary / Animal Vaccines Market by Product (Livestock, Companion, Poultry, Equine, Porcine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Swine& Avian Influenza, Strangles) & Technology (Live attenuated, DNA, Inactivated) - Global Forecast to 2020
[Lowest Price Guaranteed: $5,650]

Published by MarketsandMarkets: 09 Jun 2015 | 41620 | In Stock

Introduction

The report segments the veterinary vaccines market on the basis of products, diseases, technologies, and regions. On basis of products, the veterinary vaccines market is categorized into companion animal vaccines, livestock vaccine, poultry vaccines, porcine vaccines, equine vaccines, aquaculture vaccines, and other animal vaccines. Among these, the companion animal vaccines segment is the fastest-growing segment due to increasing prevalence of zoonotic diseases in humans and growing pet population.

The major animal vaccine production technologies include live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. The DNA vaccines segment is expected to witness highest growth in the forecast period.

New product launches and strategic collaborations were key strategies adopted by major industry players to increase their market share and cater to unmet needs. Emerging and immature markets such as the Middle East, Brazil, Argentina, Mexico, Turkey, China, and India are lucrative markets for veterinary vaccines, owing to favorable government initiatives.

From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the veterinary vaccines market and the product portfolios, developments, and strategies adopted to maintain and increase their market shares. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms, garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on product portfolios of the top players in the veterinary vaccines market. The report analyzes the veterinary vaccines market by product and geography

• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the veterinary vaccines market

• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the veterinary vaccines market

• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various product across geographies

• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the veterinary vaccines market

Table of Contents
for Veterinary / Animal Vaccines Market by Product (Livestock, Companion, Poultry, Equine, Porcine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Swine& Avian Influenza, Strangles) & Technology (Live attenuated, DNA, Inactivated) - Global Forecast to 2020

  • TABLE OF CONTENTS

    1 INTRODUCTION 17

    1.1 OBJECTIVES OF THE STUDY 17

    1.2 MARKET DEFINITION 17

    1.3 MARKET SCOPE 18

    1.3.1 MARKETS COVERED 18

    1.3.2 YEARS CONSIDERED FOR THE STUDY 20

    1.4 CURRENCY 20

    1.5 LIMITATIONS 20

    1.6 STAKEHOLDERS 21

    2 RESEARCH METHODOLOGY 22

    2.1 MARKET SIZE ESTIMATION 23

    2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 26

    2.2.1 KEY DATA FROM SECONDARY SOURCES 27

    2.2.2 KEY DATA FROM PRIMARY SOURCES 27

    2.2.2.1 Key industry insights 28

    2.2.3 ASSUMPTIONS FOR THE STUDY 28

    3 EXECUTIVE SUMMARY 29

    4 PREMIUM INSIGHTS 33

    4.1 VETERINARY VACCINES MARKET TO GROW AT A STEADY RATE 33

    4.2 VETERINARY VACCINES MARKET, BY PRODUCT 33

    4.3 VETERINARY VACCINES MARKET, BY REGION 34

    4.4 VETERINARY VACCINES MARKET, BY TECHNOLOGY 34

    4.5 LIFECYCLE ANALYSIS, BY REGION 35

    5 MARKET OVERVIEW 36

    5.1 INTRODUCTION 37

    5.2 MARKET SEGMENTATION 37

    5.3 MARKET DYNAMICS 38

    5.3.1 DRIVERS 38

    5.3.1.1 Increase in livestock and instances of disease 38

    5.3.1.2 Increasing incidence of zoonotic diseases 39

    5.3.1.3 Increasing investments by various government agencies, animal associations, and leading players 39

    5.3.1.4 Introduction of new types of vaccines 39

    5.3.2 RESTRAINTS 40

    5.3.2.1 Rising maintenance costs for storage of vaccines 40

    5.3.2.2 Increasing prices of meat promoting the rise in adoption of vegetarian diets 41

    5.3.3 OPPORTUNITIES 41

    5.3.3.1 Technological innovations such as DNA vaccines 41

    5.3.3.2 Growing awareness of animal health in emerging economies 42

    6 VETERINARY VACCINES MARKET, BY PRODUCT 43

    6.1 INTRODUCTION 44

    7 VETERINARY VACCINES MARKET, BY DISEASE 46

    7.1 INTRODUCTION 47

    7.2 PORCINE VACCINES 47

    7.2.1 SNAPSHOT: MARKET SHARE, BY DISEASE 47

    7.3 POULTRY VACCINES 49

    7.3.1 SNAPSHOT: MARKET SHARE, BY DISEASE 49

    7.4 COMPANION ANIMAL VACCINES 51

    7.5 CANINE VACCINES 51

    7.5.1 SNAPSHOT: MARKET SHARE, BY DISEASE 51

    7.6 FELINE VACCINES 53

    7.6.1 SNAPSHOT: MARKET SHARE, BY DISEASE 53

    7.7 LIVESTOCK VACCINES 54

    7.7.1 BOVINE VACCINES 54

    7.7.1.1 Snapshot: Market Share, by Disease 54

    7.7.2 SMALL RUMINANT VACCINES 56

    7.7.2.1 Snapshot: Market Share, by Disease 56

    7.8 EQUINE VACCINES 57

    7.8.1 SNAPSHOT: MARKET SHARE, BY DISEASE 57

    7.9 AQUACULTURE VACCINES 59

    7.9.1 SNAPSHOT: MARKET SHARE, BY DISEASE 59

    8 VETERINARY VACCINES MARKET, BY TECHNOLOGY 61

    8.1 INTRODUCTION 62

    8.2 LIVE ATTENUATED VACCINES (LAV) 63

    8.3 INACTIVATED VACCINES 65

    8.4 TOXOID VACCINES 67

    8.5 RECOMBINANT VACCINES 68

    8.6 CONJUGATE VACCINES 69

    8.7 SUBUNIT VACCINES 71

    8.8 DNA VACCINES 73

    9 VETERINARY VACCINES MARKET, BY REGION 74

    9.1 INTRODUCTION 75

    9.2 EUROPE 78

    9.3 NORTH AMERICA 90

    9.4 ASIA 100

    9.4.1 CHINA 101

    9.4.2 THAILAND 110

    9.4.2.1 Regulatory landscape for veterinary vaccines in Thailand 111

    9.4.3 INDIA 119

    9.5 REST OF THE WORLD (ROW) 130

    9.5.1 BRAZIL 130

    10 COMPETITIVE LANDSCAPE 140

    10.1 OVERVIEW 141

    10.2 MARKET SHARE ANALYSIS 142

    10.3 VETERINARY VACCINES MARKET, MAJOR DEVELOPMENTS, BY PRODUCT (2013–2015) 143

    10.3.1 RECENT DEVELOPMENTS BY MARKET PLAYERS (2013–2015) 144

    10.3.1.1 Zoetis (Pfizer) 144

    10.3.1.2 Merck Animal Health 144

    10.3.1.3 Boehringer Ingelheim 145

    10.3.1.4 Ceva Animal Health 145

    10.4 COMPETITIVE SITUATION AND TRENDS 146

    10.4.1 NEW PRODUCT LAUNCHES 146

    10.4.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 147

    10.4.3 ACQUISITIONS 148

    10.4.4 EXPANSION 149

    10.4.5 OTHER DEVELOPMENTS 149

    11 COMPANY PROFILES 150

    (Overview, Financials, Products & Services, Strategy, & Developments)*

    11.1 INTRODUCTION 150

    11.2 BAYER HEALTHCARE 151

    11.3 BIONICHE ANIMAL HEALTH 153

    11.4 BOEHRINGER INGELHEIM 155

    11.5 CEVA ANIMAL HEALTH 159

    11.6 ELANCO ANIMAL HEALTH (ELI LILLY) 161

    11.7 HESKA CORPORATION 164

    11.8 MERCK ANIMAL HEALTHCARE 166

    11.9 MERIAL INC. (SANOFI) 169

    11.10 VIRBAC 171

    11.11 ZOETIS 173

    *Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

    12 APPENDIX 176

    12.1 INSIGHTS OF INDUSTRY EXPERTS 176

    12.2 DISCUSSION GUIDE 177

    12.3 OTHER COMPANY DEVELOPMENTS (2013–2014) 180

    12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 183

    12.5 AVAILABLE CUSTOMIZATIONS 184

    12.6 RELATED REPORTS 185

List Of Tables
in Veterinary / Animal Vaccines Market by Product (Livestock, Companion, Poultry, Equine, Porcine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Swine& Avian Influenza, Strangles) & Technology (Live attenuated, DNA, Inactivated) - Global Forecast to 2020

LIST OF TABLES


TABLE 1 GROWING INCIDENCE OF ZOONOTIC DISEASES TO DRIVE THE VETERINARY VACCINES MARKET 40

TABLE 2 HIGH MAINTENANCE AND STORAGE COST OF VACCINES TO RESTRAIN MARKET GROWTH 41

TABLE 3 TECHNOLOGICAL ADVANCEMENTS LIKELY TO BOOST THE VETERINARY VACCINES MARKET 42

TABLE 4 VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2013–2020 ($MILLION) 45

TABLE 5 PORCINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 48

TABLE 6 POULTRY VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 50

TABLE 7 CANINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 52

TABLE 8 FELINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 54

TABLE 9 BOVINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 55

TABLE 10 SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 57

TABLE 11 EQUINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 58

TABLE 12 AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 60

TABLE 13 VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 63

TABLE 14 LIVE ATTENUATED VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 64

TABLE 15 INACTIVATED VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 66

TABLE 16 TOXOID VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 67

TABLE 17 RECOMBINANT VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 68

TABLE 18 CONJUGATE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 70

TABLE 19 SUBUNIT VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 72

TABLE 20 DNA VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 73

TABLE 21 VETERINARY VACCINES MARKET SIZE, BY REGION, 2013–2020 ($MILLION) 77

TABLE 22 EUROPE: VETERINARY VACCINES MARKET SIZE, BY PRODUCT,

2013–2020 ($MILLION) 80

TABLE 23 EUROPE: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 81

TABLE 24 EUROPE: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 82

TABLE 25 EUROPE: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY,

2013–2020 ($MILLION) 82

TABLE 26 EUROPE: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 83

TABLE 27 EUROPE: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,

2013–2020 ($MILLION) 83

TABLE 28 EUROPE: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 84

TABLE 29 EUROPE: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 84

TABLE 30 EUROPE: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 85

TABLE 31 EUROPE: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY,

2013–2020 ($MILLION) 86

TABLE 32 EUROPE: CANINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 86

TABLE 33 EUROPE: FELINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 87

TABLE 34 EUROPE: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 87

TABLE 35 EUROPE: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 88

TABLE 36 EUROPE: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 88

TABLE 37 EUROPE: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE,

2013–2020 ($MILLION) 89

TABLE 38 EUROPE: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 89

TABLE 39 NORTH AMERICA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT,

2013–2020 ($MILLION) 91

TABLE 40 NORTH AMERICA: PORCINE VACCINES MARKET SIZE, BY DISEASE,

2013–2020 ($MILLION) 91

TABLE 41 NORTH AMERICA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 92

TABLE 42 NORTH AMERICA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY,

2013–2020 ($MILLION) 92

TABLE 43 NORTH AMERICA: BOVINE VACCINES MARKET SIZE, BY DISEASE,

2013–2020 ($MILLION) 93

TABLE 44 NORTH AMERICA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,

2013–2020 ($MILLION) 93

TABLE 45 NORTH AMERICA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 94

TABLE 46 NORTH AMERICA: POULTRY VACCINES MARKET SIZE, BY DISEASE,

2013–2020 ($MILLION) 95

TABLE 47 NORTH AMERICA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 95

TABLE 48 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET SIZE,

BY CATEGORY, 2013–2020 ($MILLION) 96

TABLE 49 NORTH AMERICA: CANINE VACCINES MARKET SIZE, BY DISEASE,

2013–2020 ($MILLION) 96

TABLE 50 NORTH AMERICA: FELINE VACCINES MARKET SIZE, BY DISEASE,

2013–2020 ($MILLION) 96

TABLE 51 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET SIZE,

BY TECHNOLOGY, 2013–2020 ($MILLION) 97

TABLE 52 NORTH AMERICA: EQUINE VACCINES MARKET SIZE, BY DISEASE,

2013–2020 ($MILLION) 97

TABLE 53 NORTH AMERICA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 98

TABLE 54 NORTH AMERICA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE,

2013–2020 ($MILLION) 98

TABLE 55 NORTH AMERICA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 99

TABLE 56 CHINA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT,

2013–2020 ($MILLION) 102

TABLE 57 CHINA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 102

TABLE 58 CHINA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 103

TABLE 59 CHINA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY,

2013–2020 ($MILLION) 104

TABLE 60 CHINA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 104

TABLE 61 CHINA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,

2013–2020 ($MILLION) 105

TABLE 62 CHINA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 105

TABLE 63 CHINA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 106

TABLE 64 CHINA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 106

TABLE 65 CHINA: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY,

2013–2020 ($MILLION) 107

TABLE 66 CHINA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 107

TABLE 67 CHINA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 107

TABLE 68 CHINA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 108

TABLE 69 CHINA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 108

TABLE 70 CHINA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 109

TABLE 71 CHINA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE,

2013–2020 ($MILLION) 109

TABLE 72 CHINA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 110

TABLE 73 THAILAND: VETERINARY VACCINES MARKET SIZE, BY PRODUCT,

2013–2020 ($MILLION) 112

TABLE 74 THAILAND: PORCINE VACCINES MARKET SIZE, BY DISEASE,

2013–2020 ($MILLION) 113

TABLE 75 THAILAND: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 113

TABLE 76 THAILAND: POULTRY VACCINES MARKET SIZE, BY DISEASE,

2013–2020 ($MILLION) 114

TABLE 77 THAILAND: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 115

TABLE 78 THAILAND: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY,

2013–2020 ($MILLION) 115

TABLE 79 THAILAND: CANINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 116

TABLE 80 THAILAND: FELINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 116

TABLE 81 THAILAND: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION) 117

TABLE 82 THAILAND: LIVESTOCK ANIMAL VACCINES MARKET SIZE, BY CATEGORY,

2013–2020 ($MILLION) 117

TABLE 83 THAILAND: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 118

TABLE 84 THAILAND: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,

2013–2020 ($MILLION) 118

TABLE 85 THAILAND: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 119

TABLE 86 INDIA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT,

2013–2020 ($MILLION) 120

TABLE 87 INDIA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 121

TABLE 88 INDIA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 121

TABLE 89 INDIA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY,

2013–2020 ($MILLION) 122

TABLE 90 INDIA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 122

TABLE 91 INDIA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,

2013–2020 ($MILLION) 123

TABLE 92 INDIA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 124

TABLE 93 INDIA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 124

TABLE 94 INDIA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 125

TABLE 95 INDIA: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY,

2013–2020 ($MILLION) 125

TABLE 96 INDIA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 126

TABLE 97 INDIA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 126

TABLE 98 INDIA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 127

TABLE 99 INDIA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 127

TABLE 100 INDIA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 128

TABLE 101 INDIA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE,

2013–2020 ($MILLION) 128

TABLE 102 INDIA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 129

TABLE 103 BRAZIL: VETERINARY VACCINES MARKET SIZE, BY PRODUCT,

2013–2020 ($MILLION) 131

TABLE 104 BRAZIL: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 131

TABLE 105 BRAZIL: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 132

TABLE 106 BRAZIL: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY,

2013–2020 ($MILLION) 132

TABLE 107 BRAZIL: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 133

TABLE 108 BRAZIL: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE,

2013–2020 ($MILLION) 133

TABLE 109 BRAZIL: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 134

TABLE 110 BRAZIL: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 134

TABLE 111 BRAZIL: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 135

TABLE 112 BRAZIL: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY,

2013–2020 ($MILLION) 136

TABLE 113 BRAZIL: CANINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 136

TABLE 114 BRAZIL: FELINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 137

TABLE 115 BRAZIL: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 137

TABLE 116 BRAZIL: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION) 138

TABLE 117 BRAZIL: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 138

TABLE 118 BRAZIL: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE,

2013–2020 ($MILLION) 139

TABLE 119 BRAZIL: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY,

2013–2020 ($MILLION) 139

TABLE 120 NEW PRODUCT LAUNCHES, 2013–2015 146

TABLE 121 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013–2015 147

TABLE 122 ACQUISITIONS, 2013-2015 148

TABLE 123 EXPANSIONS, 2013-2015 149

TABLE 124 OTHER DEVELOPMENTS, 2012–2015 149

List Of Figures, Charts and Diagrams
in Veterinary / Animal Vaccines Market by Product (Livestock, Companion, Poultry, Equine, Porcine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Swine& Avian Influenza, Strangles) & Technology (Live attenuated, DNA, Inactivated) - Global Forecast to 2020

LIST OF FIGURES


FIGURE 1 RESEARCH DESIGN: VETERINARY VACCINES MARKET 22

FIGURE 2 MARKET SIZE ESTIMATION APPROCH 24

FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 25

FIGURE 4 DATA TRIANGULATION METHODOLOGY 26

FIGURE 5 VETERINARY VACCINES MARKET SNAPSHOT (2015 VS. 2020): COMPANION ANIMAL VACCINES SEGMENT TO GROW AT THE HIGHEST CAGR 29

FIGURE 6 LIVE ATTENUATED VACCINES SEGMENT IS EXPECTED TO DOMINATE THE VETERINARY VACCINES TECHNOLOGIES MARKET IN 2015 30

FIGURE 7 PORCINE CIRCOVIRUS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR IN THE PORCINE VACCINES MARKET 31

FIGURE 8 CANINE RABIES VACCINES SEGMENT WILL CONTINUE TO DOMINATE THE CANINE VACCINES MARKET 31

FIGURE 9 ASIA-PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 32

FIGURE 10 ATTRACTIVE MARKET OPPORTUNITIES 33

FIGURE 11 PORCINE VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE IN 2014 33

FIGURE 12 ASIA IS EXPECTED TO BE THE FASTEST-GROWING REGION DURING THE FORECAST PERIOD 34

FIGURE 13 LIVE ATTENUATED VACCINES TECHNOLOGY SEGMENT IS EXPECTED TO DOMINATE THE VETERINARY VACCINES MARKET DURING THE FORECAST PERIOD 34

FIGURE 14 ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD 35

FIGURE 15 INCREASING INCIDENCE OF ZOONOTIC DISEASES TO BOOST MARKET GROWTH 38

FIGURE 16 PORCINE VACCINES COMMANDED LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN 2014 44

FIGURE 17 PORCINE CIRCOVIRUS SEGMENT PROJECTED TO GROW AT HIGHEST RATE IN PORCINE VACCINES MARKET, BY 2020 48

FIGURE 18 INFECTIOUS BRONCHITIS SEGMENT DOMINATED THE POULTRY VACCINES MARKET IN 2014 50

FIGURE 19 CANINE DISTEMPER SEGMENT PROJECTED TO GROW AT HIGHEST RATE IN CANINE VACCINES MARKET BY 2020 52

FIGURE 20 FELINE RABIES SEGMENT DOMINATED FELINE VACCINES MARKET IN 2014 53

FIGURE 21 BVD SEGMENT PROJECTED TO GROW AT HIGHEST RATE IN BOVINE VACCINES MARKET BY 2020 55

FIGURE 22 CLOSTRIDIAL DISEASES SEGMENT DOMINATED THE SMALL RUMINANT VACCINES MARKET IN 2014 56

FIGURE 23 EQUINE RHINOPNEUMONITIS SEGMENT PROJECTED TO GROW AT HIGHEST RATE IN EQUINE VACCINES MARKET BY 2020 58

FIGURE 24 VIBRIOSIS SEGMENT DOMINATED THE AQUACULTURE VACCINES MARKET IN 2014 59

FIGURE 25 LIVE ATTENUATED VACCINES DOMINATED THE GLOBAL VETERINARY VACCINES MARKET IN 2014 62

FIGURE 26 POULTRY VACCINES DOMINATED THE LIVE ATTENUATED VACCINES MARKET IN 2014 64

FIGURE 27 COMPANION ANIMAL VACCINES TO WITNESS THE HIGHEST GROWTH RATE IN THE INACTIVATED VACCINES MARKET BY 2020 65

FIGURE 28 LIVESTOCK VACCINES DOMINATED THE TOXOID VACCINES MARKET IN 2014 67

FIGURE 29 PORCINE VACCINES TO GROW AT THE HIGHEST RATE IN THE RECOMBINANT VACCINES MARKET BY 2020 68

FIGURE 30 PORCINE VACCINES DOMINATED THE CONJUGATE VACCINES MARKET IN 2014 69

FIGURE 31 LIVESTOCK VACCINES TO GROW AT THE HIGHEST RATE IN THE SUBUNIT VACCINES MARKET BY 2020 71

FIGURE 32 PORCINE VACCINES DOMINATED THE DNA VACCINES MARKET IN 2014 73

FIGURE 33 GEOGRAPHIC SNAPSHOT ASIA TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD 75

FIGURE 34 ASIA, AN ATTRACTIVE DESTINATION FOR ALL PRODUCT CATEGORIES 76

FIGURE 35 EUROPE WILL CONTINUE TO LEAD THE GLOBAL VETERINARY VACCINES MARKET IN THE FORECAST PERIOD 76

FIGURE 36 THE DEMAND FOR VETERINARY VACCINES WILL BE DRIVEN BY THE GROWING PRODUCTION OF PIG MEAT IN THE FORECAST PERIOD 79

FIGURE 37 THE PORCINE VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN VETERINARY VACCINES MARKET, BY PRODUCT 80

FIGURE 38 RECOMBINANT VACCINES TECHNOLOGY WILL BE THE FASTEST-GROWING SEGMENT IN EUROPEAN VETERINARY VACCINESMARKET IN THE FORECAST PERIOD 81

FIGURE 39 THE INACTIVATED VACCINES TECHNOLOGY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN COMPANION ANIMAL VACCINES MARKET 85

FIGURE 40 COMPANION ANIMAL VACCINES WILL BE THE FASTEST-GROWING SEGMENT FOR NORTH AMERICAN VETERINARY VACCINES MARKET IN THE FORECAST PERIOD 90

FIGURE 41 THE LIVE ATTENUATED VACCINES TECHNOLOGY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICA LIVESTOCK VACCINES MARKET 94

FIGURE 42 ASIA MARKET SNAPSHOT: THE DEMAND FOR VETERINARY VACCINES WILL BE DRIVEN BY INCREASING INCIDENCES OF ZOONOTIC DISEASES 100

FIGURE 43 THE LIVESTOCK VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN CHINA 101

FIGURE 44 CONJUGATE VACCINES TECHNOLOGY WILL BE THE FASTEST-GROWING SEGMENT FOR ASIAN VETERINARY VACCINES MARKET IN THE FORECAST PERIOD 103

FIGURE 45 THE PORCINE VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE THAILAND VETERINARY VACCINES MARKET 112

FIGURE 46 RECOMBINANT VACCINE TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH THAILAND VETERINARY VACCINES MARKET IN THE FORECAST PERIOD 114

FIGURE 47 THE LIVESTOCK VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN INDIA 120

FIGURE 48 CONJUGATE VACCINES TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN LIVESTOCK VACCINES MARKET THE FORECAST PERIOD 123

FIGURE 49 THE POULTRY VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN BRAZIL 130

FIGURE 50 INACTIVATED VACCINES TECHNOLOGY SEGMENT TO GROW AT THE HIGHEST CAGR IN POULTRY VACCINES MARKET IN THE FORECAST PERIOD 135

FIGURE 51 COMPANIES ADOPTED NEW PRODUCT LAUNCHES AND LICENSES AS THEIR KEY GROWTH STRATEGY (2013-2015) 141

FIGURE 52 GLOBAL VETERINARY VACCINES MARKET SHARE, BY KEY PLAYER, 2014 142

FIGURE 53 VETERINARY VACCINES MARKET, MAJOR DEVELOPMENTS (2013–2015) 143

FIGURE 54 ZOETIS (PFIZER) FOCUSED ON PORCINE SEGMENT IN LAST FEW YEARS

(2013-2015) 144

FIGURE 55 MERCK CONCENTRATED ON LIVESTOCK SEGMENT (2013-2015) 144

FIGURE 56 BOEHRINGER INGELHEIM MAINLY CONCENTRATED ON EQUINE SEGMENT (2013-2015) 145

FIGURE 57 CEVA RELEASED NEW PRODUCTS FOR THE POULTRY SEGMENT (2013 – 2015) 145

FIGURE 58 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY GROWTH STRATEGY 146

FIGURE 59 GEOGRAPHIC REVENUE MIX OF TOP FIVE MARKET PLAYERS 150

FIGURE 60 BAYER HEALTHCARE: COMPANY SNAPSHOT 151

FIGURE 61 BIONICHE ANIMAL HEALTH: COMPANY SNAPSHOT 153

FIGURE 62 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT 155

FIGURE 63 CEVA ANIMAL HEALTH: COMPANY SNAPSHOT 159

FIGURE 64 ELANCO ANIMAL HEALTH: COMPANY SNAPSHOT 161

FIGURE 65 HESKA CORPORATION: COMPANY SNAPSHOT 164

FIGURE 66 MERCK ANIMAL HEALTHCARE: COMPANY SNAPSHOT 166

FIGURE 67 MERIAL INC. (SANOFI): COMPANY SNAPSHOT 169

FIGURE 68 VIRBAC: COMPANY SNAPSHOT 171

FIGURE 69 ZOETIS: COMPANY SNAPSHOT 173

Additional Details

Publisher

MarketsandMarkets

Publisher Information

Reference

41620 | PH 3475

Number of Pages

186

Report Format

PDF

MarketsandMarkets Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Eagle Veterinary Technology Co., Ltd. (044960) - Financial and Strategic SWOT Analysis Review
SummaryEagle Veterinary Technology Co., Ltd. (EVTC) is a pharmaceutical company that manufactures an...
11 Jul 2016 by Global Data USD $300 More Info
Premier Veterinary Group Plc (PVG) - Financial and Strategic SWOT Analysis Review
SummaryPremier Veterinary Group Plc (Premier Veterinary), formerly ARK Therapeutics Group Plc is a v...
11 Jul 2016 by Global Data USD $300 More Info
Veterinary Reference Laboratory Market by Technology (Clinical Chemistry, Hematology, Immunodiagnostics, Molecular Diagnostics), Application (Pathology, Bacteriology, Virology, Parasitology), Animal (Dog, Cat, Cattle, Pig) - Global Forecast to 2021
The global veterinary reference laboratories market is estimated to grow at a CAGR of 9.8% from 2016...
07 Jun 2016 by MarketsandMarkets USD $5,650 More Info
Premier Veterinary Group Plc (PVG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryPremier Veterinary Group Plc (Premier Veterinary), formerly ARK Therapeutics Group Plc is a v...
10 May 2016 by Global Data USD $250 More Info
Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs
Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover DrugsS...
01 May 2016 by CBR Pharma Insights USD $2,995 More Info
Eagle Veterinary Technology Co., Ltd. (044960) - Financial and Strategic SWOT Analysis Review
SummaryEagle Veterinary Technology Co., Ltd. (EVTC) is a pharmaceutical company that manufactures an...
15 Apr 2016 by Global Data USD $300 More Info
Analytical Standards Market by Technique (Chromatography, Spectroscopy, Titrimetry, Physical Property Testing), Application (Food & Beverage, Environmental, Pharmaceutical, Cosmetic, Veterinary, Forensics, Petrochemistry) - Global Forecast to 2020
The global analytical standards market is estimated to grow at a CAGR of 6.5% from 2015 to 2020 and ...
05 Apr 2016 by MarketsandMarkets USD $4,650 More Info
Veterinary Vaccines
Veterinary Vaccines Market research report covers the Types of Veterinary Vaccines and the different...
01 Apr 2016 by USD $3,600 More Info
Eagle Veterinary Technology Co., Ltd. (044960) - Financial and Strategic SWOT Analysis Review
SummaryEagle Veterinary Technology Co., Ltd. (EVTC) is a pharmaceutical company that manufactures an...
09 Jan 2016 by Global Data USD $300 More Info
Eagle Veterinary Technology Co., Ltd. (044960) - Financial and Strategic SWOT Analysis Review
SummaryEagle Veterinary Technology Co., Ltd. (EVTC) is a pharmaceutical company that manufactures an...
08 Nov 2015 by Global Data USD $300 More Info

This report is published by MarketsandMarkets

Download Free Report Summary PDF

Veterinary / Animal Vaccines Market by Product (Livestock, Companion, Poultry, Equine, Porcine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Swine& Avian Influenza, Strangles) & Technology (Live attenuated, DNA, Inactivated) - Global Forecast to 2020 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...